Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn
Research ArticleToxicology

Urolithin A mitigates cisplatin-induced nephrotoxicity by inhibiting renal inflammation and apoptosis in an experimental rat model

Melissa Guada, Raghu Ganugula, Manicka Vadhanam and Ravi Kumar Majeti
Journal of Pharmacology and Experimental Therapeutics August 7, 2017, jpet.117.242420; DOI: https://doi.org/10.1124/jpet.117.242420
Melissa Guada
1 Texas A&M University;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Raghu Ganugula
1 Texas A&M University;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Manicka Vadhanam
2 University of Louisville
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ravi Kumar Majeti
1 Texas A&M University;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF + SI
  • PDF
Loading

Article Information

jpet.117.242420
DOI 
https://doi.org/10.1124/jpet.117.242420
PubMed 
28784820

Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0022-3565
Online ISSN 
1521-0103
History 
  • Published online August 7, 2017.

Article Versions

  • You are currently viewing an Earlier version of this article (August 7, 2017 - 08:39).
  • View the most recent version of this article
Copyright & Usage 
The American Society for Pharmacology and Experimental Therapeutics

Author Information

  1. Melissa Guada1,
  2. Raghu Ganugula1,
  3. Manicka Vadhanam2, and
  4. Ravi Kumar Majeti1,*
  1. 1 Texas A&M University;
  2. 2 University of Louisville
  1. ↵*Address correspondence to: mnvrkumar{at}tamhsc.edu

Statistics from Altmetric.com

Article usage

Article usage: August 2017 to March 2023

AbstractFullPdf
Aug 20171950121
Sep 20172935077
Oct 20171612769
Nov 20171231353
Dec 2017106937
Jan 2018104926
Feb 201875722
Mar 2018146635
Apr 201866522
May 201895324
Jun 201867327
Jul 201831414
Aug 2018361010
Sep 2018271619
Oct 2018242543
Nov 201894346
Dec 2018153527
Jan 201923852
Feb 2019123726
Mar 201923647
Apr 201925036
May 201918030
Jun 201953426
Jul 201943234
Aug 2019211022
Sep 2019413431
Oct 201924325
Nov 201934123
Dec 201963214
Jan 202042617
Feb 202013325
Mar 202012214
Apr 202011612
May 202002729
Jun 202011110
Jul 202031911
Aug 202013436
Sep 202054822
Oct 202013313
Nov 202013630
Dec 202072720
Jan 2021142516
Feb 202182324
Mar 2021134119
Apr 202133016
May 202184421
Jun 202152117
Jul 202192147
Aug 20218199
Sep 202191618
Oct 202161731
Nov 202141942
Dec 202162012
Jan 202262242
Feb 202252232
Mar 202246628
Apr 202243827
May 202233529
Jun 202282928
Jul 202252423
Aug 202283417
Sep 202282423
Oct 202233020
Nov 202223214
Dec 202281422
Jan 202352224
Feb 202342515
Mar 202354627

Next
Back to top

In this issue

Journal of Pharmacology and Experimental Therapeutics: 385 (1)
Journal of Pharmacology and Experimental Therapeutics
Vol. 385, Issue 1
1 Apr 2023
  • Table of Contents
  • About the Cover
  • Index by author
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Journal of Pharmacology and Experimental Therapeutics article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Urolithin A mitigates cisplatin-induced nephrotoxicity by inhibiting renal inflammation and apoptosis in an experimental rat model
(Your Name) has forwarded a page to you from Journal of Pharmacology and Experimental Therapeutics
(Your Name) thought you would be interested in this article in Journal of Pharmacology and Experimental Therapeutics.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleToxicology

Urolithin A mitigates cisplatin-induced nephrotoxicity by inhibiting renal inflammation and apoptosis in an experimental rat model

Melissa Guada, Raghu Ganugula, Manicka Vadhanam and Ravi Kumar Majeti
Journal of Pharmacology and Experimental Therapeutics August 7, 2017, jpet.117.242420; DOI: https://doi.org/10.1124/jpet.117.242420

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleToxicology

Urolithin A mitigates cisplatin-induced nephrotoxicity by inhibiting renal inflammation and apoptosis in an experimental rat model

Melissa Guada, Raghu Ganugula, Manicka Vadhanam and Ravi Kumar Majeti
Journal of Pharmacology and Experimental Therapeutics August 7, 2017, jpet.117.242420; DOI: https://doi.org/10.1124/jpet.117.242420
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF + SI
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Nafamostat is a Potent Human Diamine Oxidase Inhibitor
  • Chemoproteomics Investigation of Testicular Toxicity with BTK Inhibitor
  • Bosentan Alters Bile Salt Disposition
Show more Toxicology

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics